This research demonstrates stability and enhanced antibacterial effects of Forsythia oil microemulsions, highlighting surfactant roles.
This study developed a stable Forsythia essential oil (FEO) microemulsion (FEO-ME) using a self-microemulsifying drug delivery system (SMEDDS). The FEO-ME effectively reduced the volatility of essential oil and inhibited bioactive component degradation. By constructing pseudoternary phase diagrams, the optimal formulation was identified, utilizing the surfactant EL-40 and cosurfactant ethanol. The resulting microemulsion exhibited an average droplet size of 21.58 nm and an encapsulation efficiency of 85.6%. FEO-ME demonstrated excellent storage stability over 15 days, with minimal changes in droplet size and polydispersity index (PDI), ensuring long-term reliability. Additionally, antibacterial tests revealed enhanced efficacy against compared to raw FEO. These findings highlight the potential of FEO-ME to enhance the bioactivity, stability, and applicability of essential oils with promising applications in food preservation, pharmaceuticals, and other industries.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: